This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Matthias Spranger, MD; Stefan Schwab, MD; Sebastian Krempien, MD; Martin Winterholler, MD; Thorsten Steiner, MD; Werner Hacke, MD

Arch Neurol. 1996;53(10):992-996.

Abstract
Background
The clinical course of bacterial meningitis still is characterized by a high mortality and frequent neurological deficits in survivors. In addition to other potentially neurotoxic mediators of inflammation, the excitatory amino acid glutamate, which has been implicated in neuronal death in a variety of other neurological diseases, may also be involved in the pathological process of bacterial meningitis.

Objectives
To investigate the prognostic value of the glutamate concentration in the cerebrospinal fluid (CSF) of patients with bacterial meningitis.

Patients and Methods
Thirty consecutive patients with bacterial meningitis were included in a prospective study. The clinical severity of the disease was assessed on admission and 14 days after the beginning of antibiotic treatment by means of the Glasgow Coma Scale. Studies of CSF were performed on admission and after 3 to 6 days. In addition to standard CSF investigations, including cell count, cytologic findings, protein analysis, glucose and lactate levels, and microbiological tests, the concentration of glutamate in the CSF was measured by an enzymatic assay.

Results
At admission, both CSF cell count and concentration of glutamate correlated well with the severity of the disease. After treatment, glutamate concentrations decreased significantly to normal or only slightly elevated levels in 23 patients. However, in 7 patients glutamate levels remained markedly increased. In this group, clinical outcome was significantly worse than in the group of patients with low glutamate levels in the second CSF analysis.

Conclusions
A prolonged increase of glutamate levels in the CSF may predict poor clinical outcome in patients with bacterial meningitis, possibly because of the sustained neurotoxic effects of this excitatory neurotransmitter.

Author Affiliations
From the Department of Neurology, University of Heidelberg, Heidelberg, Germany (Drs Spranger, Schwab, Krempien, Steiner, and Hacke); and Department of Neurology, University of Erlangen, Erlangen, Germany (Dr Winterholler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Meningococcal ABC-Type L-Glutamate Transporter GltT Is Necessary for the Development of Experimental Meningitis in Mice
Colicchio et al.
Infect. Immun. 2009;77:3578-3587.
ABSTRACT | FULL TEXT  

Sleep disorders are long-term sequelae of both bacterial and viral meningitis
Schmidt et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:554-558.
ABSTRACT | FULL TEXT